Prosecution Insights
Last updated: August 18, 2026

Examiner: WISTNER, SARAH CLINKSCALES

Tech Center 1600 • Art Units: 1616

This examiner grants 22% of resolved cases

Performance Statistics

21.7%
Allow Rate
-38.3% vs TC avg
80
Total Applications
+74.4%
Interview Lift
1240
Avg Prosecution Days
Based on 23 resolved cases, 2023–2026

Rejection Statute Breakdown

2.0%
§101 Eligibility
16.0%
§102 Novelty
33.7%
§103 Obviousness
25.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19083627 HEMOSTATIC COMPOSITIONS AND RELATED METHODS Non-Final OA Boston Scientific Scimed, Inc.
18265721 C13 - HYDROCARBON MIXTURE AND USE THEREOF Final Rejection BASF SE
19002887 NOVEL PHOTONIC CRYSTAL PROTEINS FROM ATRINA SP. BYSSUS AND USES THEREOF Non-Final OA POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
18770842 COMPOSITION FOR SOLID DISPERSION, SOLID DISPERSION, AND METHOD OF MANUFACTURING THE SOLID DISPERSION Non-Final OA Shin-Etsu Chemical Co., Ltd.
18260420 HYDROXY-SUBSTITUTED SPHINGOLIPIDS Final Rejection Evonik Operations GmbH
18257022 COMPOSITION FOR CARING FOR THE SKIN Non-Final OA L'OREAL
18255061 COMPOSITION FOR KERATIN FIBERS Non-Final OA L'OREAL
18253667 COMPOSITION COMPRISING A PARTICULAR OXIDATION DYEING BASE, AT LEAST ONE GUAR GUM AND AT LEAST ONE FATTY SUBSTANCE Final Rejection L'Oreal
18973959 Oral Care Compositions Non-Final OA Colgate-Palmolive Company
17780015 METHOD FOR IMPROVING THE TACTILE SENSATION OF DYED KERATINOUS MATERIAL, ESPECIALLY HUMAN HAIR Final Rejection Henkel AG & Co. KGaA
18251786 SEED COATING COMPOSITIONS Non-Final OA Dow Global Technologies LLC
18933238 MASCARA COMPOSITION Non-Final OA L’ORÉAL
18203798 ANHYDROUS COSMETIC COMPOSITION Non-Final OA L’ORÉAL
18247219 HAIR CLEANSING COMPOSITION Final Rejection Kao Corporation
17995635 METHOD FOR PRODUCING CARBON DIOXIDE-CONTAINING HYDROGEL ARTICLE Non-Final OA Kao Corporation
18276518 MEDICAMENT FOR PREVENTION AND TREATMENT OF HYPERPIGMENTATION Final Rejection SYMRISE AG
17948277 Refillable Implantable Device for Delivering a Drug Compound Non-Final OA Celanese EVA Performance Polymers LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month